2-[(5S)-4,7-bis(carboxymethyl)-5-[[4-(ethanethioylamino)phenyl]methyl]-1,4,7-triazonan-1-yl]acetic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-[(5S)-4,7-bis(carboxymethyl)-5-[[4-(ethanethioylamino)phenyl]methyl]-1,4,7-triazonan-1-yl]acetic acid
• 化学式: C₂₁H₃₀N₄O₆S
• 分子量: 466.6
• InChiKey: CNXIJLUZGQRWGB-SFHVURJKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -6.1
• 重原子数：
  32
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  166
• 氢给体数：
  4
• 氢受体数：
  10

文献信息

• Chelated PSMA Inhibitors
  申请人：Berkman Clifford

  公开号：US20140241985A1

  公开（公告）日：2014-08-28

  Compounds as defined herein are provided which are useful in (1) diagnostic methods for detecting and/or identifying cells presenting PSMA; (2) compositions comprising a compound of the invention together with a pharmaceutically acceptable diluent; and (3) methods for imaging prostate cancer cells.

  本文提供了化合物，其用于：(1)检测和/或鉴定呈现PSMA的细胞的诊断方法；(2)包含本发明化合物和药学可接受稀释剂的组合物；以及(3)成像前列腺癌细胞的方法。
• Chelated PSMA inhibitors
  申请人：Cancer Targeted Technology

  公开号：US10166301B2

  公开（公告）日：2019-01-01

  Compounds as defined herein are provided which are useful in (1) diagnostic methods for detecting and/or identifying cells presenting PSMA; (2) compositions comprising a compound of the invention together with a pharmaceutically acceptable diluent; and (3) methods for imaging prostate cancer cells.

  本文所定义的化合物可用于：(1) 检测和/或识别呈现 PSMA 的细胞的诊断方法；(2) 由本发明化合物和药学上可接受的稀释剂组成的组合物；(3) 前列腺癌细胞成像方法。
• US9446157B2
  申请人：——

  公开号：US9446157B2

  公开（公告）日：2016-09-20
• [EN] ALBUMIN-BINDING PSMA INHIBITORS<br/>[FR] INHIBITEURS DE PSMA SE LIANT À L'ALBUMINE
  申请人：CANCER TARGETED TECH LLC

  公开号：WO2018098390A1

  公开（公告）日：2018-05-31

  Provided herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof, wherein L1 and L2 are each independently a covalent bond or a divalent linking group, R is a detectable label or therapeutic drug and B is an albumin binding moiety. Also provided are compositions including a compound of Formula (I) together with a pharmaceutically acceptable carrier, and methods for imaging prostate cancer cells using a compound of Formula (I).